How do I use and interpret a D-dimer test to rule out deep‑vein thrombosis or pulmonary embolism?

D-Dimer Testing for DVT and PE: Evidence-Based Approach

D-dimer testing should only be used to rule out venous thromboembolism in patients with low or intermediate pretest probability—never order it in high-risk patients, and always use age-adjusted cutoffs (age × 10 ng/mL) in patients over 50 years old. 1

Step 1: Assess Pretest Probability First

Before ordering any D-dimer test, you must stratify patients using validated clinical prediction rules such as the Wells score or revised Geneva score to determine pretest probability (low, intermediate, or high). 1, 2 This is non-negotiable—clinical assessment alone is unreliable, with only 20% of suspected DVT cases actually having the diagnosis. 2

Step 2: Apply the Pulmonary Embolism Rule-Out Criteria (PERC) for Low-Risk PE

For patients with LOW pretest probability of PE, apply all 8 PERC criteria before ordering D-dimer: 1

• Age < 50 years
• Pulse < 100 bpm
• SaO2 > 94%
• No unilateral leg swelling
• No hemoptysis
• No recent trauma or surgery
• No history of VTE
• No oral hormone use

If all 8 PERC criteria are met, do NOT order D-dimer or imaging—the risk of PE is lower than the risks of testing (approximately 1%). 1 This approach has a pooled sensitivity of 97% and safely avoids unnecessary testing in 22% of patients. 1

Step 3: D-Dimer Testing Strategy by Risk Category

Low or Intermediate Pretest Probability

Order a high-sensitivity D-dimer assay (ELISA-based) as the initial diagnostic test. 1 The quantitative ELISA assays have 99% negative predictive value when combined with low-to-moderate pretest probability assessment. 2

Critical interpretation thresholds: 1

• Patients ≤ 50 years: Use standard cutoff of 500 ng/mL (or < 0.5 μg FEU/mL)
• Patients > 50 years: Use age-adjusted cutoff = age × 10 ng/mL
  • Example: A 75-year-old patient's cutoff is 750 ng/mL

The age-adjusted approach increases specificity from 10% to 30% in elderly patients without missing PE cases (maintains >97% sensitivity). 1 In patients ≥75 years, this triples the proportion who can safely avoid imaging (from 8.7% to 26.1%). 3

If D-dimer is below the appropriate cutoff: PE/DVT is ruled out—do NOT order imaging. 1, 4

If D-dimer is elevated: Proceed directly to imaging (CTPA for PE, compression ultrasound for DVT). 1

High Pretest Probability

Do NOT order D-dimer testing. 1 A negative D-dimer does not safely exclude PE even with highly sensitive assays in high-risk patients. 4 Proceed directly to imaging with CTPA (or V/Q scan if CTPA contraindicated). 1

Step 4: Recognize D-Dimer Limitations

D-dimer has low specificity and is frequently elevated in: 2, 4, 5

• Hospitalized patients
• Recent surgery or major trauma
• Cancer patients
• Pregnancy
• Severe infection or inflammatory disease
• Elderly patients

In these populations, D-dimer utility is significantly reduced—the number needed to test rises from 3 to >10. 4 Consider proceeding directly to imaging in hospitalized patients or those with multiple comorbidities where false positives are expected. 2, 5

Step 5: Assay Selection Matters

Only use high-sensitivity quantitative D-dimer assays (ELISA or equivalent) with validated sensitivity ≥97% and negative predictive value ≥98%. 2, 6 Older latex agglutination or whole blood assays have insufficient sensitivity (87-92%) and should only be used in low pretest probability patients, not intermediate-risk patients. 1, 6

Common Pitfalls to Avoid

• Never use D-dimer as a screening test in all patients with dyspnea or chest pain—this leads to excessive false positives and unnecessary downstream testing. 1
• Never order imaging after a negative D-dimer in low/intermediate probability patients—this defeats the purpose of the test and exposes patients to unnecessary radiation and contrast. 1, 4
• Never skip the pretest probability assessment—ordering D-dimer without clinical stratification is inappropriate and leads to misinterpretation. 1, 2
• Never use the standard 500 ng/mL cutoff in elderly patients—you will miss the opportunity to safely avoid imaging in 20-30% of patients over 75 years. 1, 3

Alternative: Clinical Probability-Adjusted Cutoffs (YEARS Algorithm)

The YEARS model offers an alternative approach using three clinical items (signs of DVT, hemoptysis, PE more likely than alternative diagnosis): 4

• No clinical items present: PE excluded if D-dimer < 1000 ng/mL
• One or more clinical items: PE excluded if D-dimer < 500 ng/mL

This approach maintains safety while increasing the proportion of patients who avoid imaging, though it has lower strength of recommendation due to limited validation. 4